This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kwok, S. Articles by Park, S. Search for Related Content PubMed PubMed Citation Articles by Kwok, S. Articles by Park, S. Social Bookmarking                         What's this?

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study

Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, South Korea

JH Ju

Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, South Korea

CS Cho

Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, South Korea

HY Kim

Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, South Korea

SH Park

Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, South Korea

The study was undertaken to investigate clinical characteristics of thrombotic thrombocytopenic purpura (TTP) in patients with SLE and to determine risk factors and clinical outcome of TTP in patients with SLE. Among the 1203 patients with SLE admitted to catholic medical centre of the catholic university of Korea from January 1990 to December 2006, 26 patients with SLE were found to admit with TTP. TTP was defined if microangiopathic haemolytic anaemia, thrombocytopenia and negative Coombs’ test were present and when at least one of the following signs was noted: renal impairment, neurologic deficit or fever. Eighty-seven patients with SLE who admitted with other manifestations, matched for age and sex, were included as disease controls. Data were retrospectively analysed based on medical records. There were no significant demographic characteristics between SLE patients with TTP and those with other manifestations. Multivariate analysis showed that independent risk factors for the development of TTP included high SLE disease activity index score (SLEDAI > 10, P = 0.006) and coexisting nephritis (P = 0.004). Among the 26 SLE patients with TTP, 12 died during admission period (in-hospital mortality rate: 46.1%). SLE patients with infection or neurologic manifestations had higher mortality rates. Multivariate analysis showed that infection is the only independent risk factor for mortality in SLE patients with TTP (P = 0.035). Patients with SLE who are in the active stage or who have renal involvement have the increased risk for TTP. Development of TTP in patients with SLE can be fatal. Therefore, intensive therapy will be needed especially in the presence of infection.

Key Words: infection • nephritis • systemic lupus erythematosus • thrombotic thrombocytopenic purpura

Lupus, Vol. 18, No. 1, 16-21 (2009)
DOI: 10.1177/0961203308094360


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. Hunt Microangiopathic haemolytic anaemias in systemic lupus erythematosus Lupus, October 1, 2009; 18(11): 1028 - 1028. [PDF]